ATAI
Price
$2.34
Change
-$0.15 (-6.02%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
498.84M
76 days until earnings call
VTGN
Price
$2.39
Change
-$0.03 (-1.24%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
69.99M
Interact to see
Advertisement

ATAI vs VTGN

Header iconATAI vs VTGN Comparison
Open Charts ATAI vs VTGNBanner chart's image
ATAI Life Sciences
Price$2.34
Change-$0.15 (-6.02%)
Volume$18.46K
Capitalization498.84M
VistaGen Therapeutics
Price$2.39
Change-$0.03 (-1.24%)
Volume$620
Capitalization69.99M
ATAI vs VTGN Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. VTGN commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (ATAI: $2.49 vs. VTGN: $2.42)
Brand notoriety: ATAI and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 332% vs. VTGN: 179%
Market capitalization -- ATAI: $498.84M vs. VTGN: $69.99M
ATAI [@Biotechnology] is valued at $498.84M. VTGN’s [@Biotechnology] market capitalization is $69.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 7 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 7 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than VTGN.

Price Growth

ATAI (@Biotechnology) experienced а +20.87% price change this week, while VTGN (@Biotechnology) price change was +0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.47%, and the average quarterly price growth was +1.42%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($499M) has a higher market cap than VTGN($70M). ATAI YTD gains are higher at: 87.218 vs. VTGN (-17.797). VTGN has higher annual earnings (EBITDA): -52.22M vs. ATAI (-124.33M). VTGN (88.6M) and ATAI (85.9M) have equal amount of cash in the bank . VTGN has less debt than ATAI: VTGN (1.71M) vs ATAI (23.8M). VTGN has higher revenues than ATAI: VTGN (698K) vs ATAI (331K).
ATAIVTGNATAI / VTGN
Capitalization499M70M713%
EBITDA-124.33M-52.22M238%
Gain YTD87.218-17.797-490%
P/E RatioN/AN/A-
Revenue331K698K47%
Total Cash85.9M88.6M97%
Total Debt23.8M1.71M1,389%
FUNDAMENTALS RATINGS
ATAI vs VTGN: Fundamental Ratings
ATAI
VTGN
OUTLOOK RATING
1..100
2824
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3658
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
37n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (44) in the Biotechnology industry is in the same range as ATAI (68) in the Miscellaneous Commercial Services industry. This means that VTGN’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Profit vs Risk Rating (95) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VTGN’s over the last 12 months.

ATAI's SMR Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VTGN’s over the last 12 months.

ATAI's Price Growth Rating (36) in the Miscellaneous Commercial Services industry is in the same range as VTGN (58) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VTGN’s over the last 12 months.

ATAI's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 29 days ago
85%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLGAX36.05N/A
N/A
Macquarie Large Cap Growth Fund A
KTCCX13.48N/A
N/A
DWS Science and Technology C
CSSJX24.29N/A
N/A
Carillon Chartwell Small Cap C
AVEEX12.60N/A
N/A
Avantis® Emerging Markets Equity Instl
SHDPX8.66-0.06
-0.69%
American Beacon Shapiro SMID Cap Eq Inv